Integra LifeSciences Holdings Corporation (IART)
NASDAQ: IART · Real-Time Price · USD
13.56
+0.27 (2.03%)
At close: Jun 6, 2025, 4:00 PM
13.57
+0.01 (0.07%)
After-hours: Jun 6, 2025, 6:17 PM EDT
IART Revenue
Integra LifeSciences Holdings had revenue of $382.65M in the quarter ending March 31, 2025, with 3.74% growth. This brings the company's revenue in the last twelve months to $1.62B, up 6.19% year-over-year. In the year 2024, Integra LifeSciences Holdings had annual revenue of $1.61B with 4.47% growth.
Revenue (ttm)
$1.62B
Revenue Growth
+6.19%
P/S Ratio
0.64
Revenue / Employee
$369,497
Employees
4,396
Market Cap
1.05B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 1.61B | 68.95M | 4.47% |
Dec 31, 2023 | 1.54B | -16.09M | -1.03% |
Dec 31, 2022 | 1.56B | 15.22M | 0.99% |
Dec 31, 2021 | 1.54B | 170.58M | 12.43% |
Dec 31, 2020 | 1.37B | -145.69M | -9.60% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 410.06B |
Johnson & Johnson | 89.33B |
Merck & Co. | 63.92B |
AbbVie | 57.37B |
AstraZeneca | 54.98B |
Novartis AG | 53.22B |
Eli Lilly and Company | 49.00B |
Novo Nordisk | 43.92B |
IART News
- 9 days ago - Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Integra LifeSciences Holdings Corporation (IART) And Encourages Shareholders to Reach Out - Accesswire
- 10 days ago - Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Integra LifeSciences Holdings Corporation (IART) and Encourages Shareholders to Learn More About the Investigation - Accesswire
- 11 days ago - Integra LifeSciences Holdings Corporation (IART) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - Accesswire
- 12 days ago - Bronstein, Gewirtz & Grossman, LLC Encourages Integra LifeSciences Holdings Corporation (IART) Shareholders to Inquire about Securities Investigation - Accesswire
- 13 days ago - Integra LifeSciences Holdings Corporation (IART) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - Accesswire
- 14 days ago - Bronstein, Gewirtz & Grossman, LLC Is Investigating Integra LifeSciences Holdings Corporation (IART) And Encourages Investors to Connect - Accesswire
- 16 days ago - Bronstein, Gewirtz & Grossman, LLC Encourages Integra LifeSciences Holdings Corporation (IART) Stockholders to Inquire about Securities Investigation - Accesswire
- 17 days ago - Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Integra LifeSciences Holdings Corporation (IART) and Encourages Investors to Learn More About the Investigation - Accesswire